Chenghui Shuangda
Shanghai, June 26, 2025 – The three-day CPHI China exhibition concluded successfully at the Shanghai New International Expo Centre. Shandong Chenghui Pharmaceutical Group made an impressive display of its specialty APIs, advanced intermediates, and CDMO services, attracting extensive in-depth discussions with numerous domestic and international clients.
Throughout the event, Chenghui’s professional team warmly engaged with over 100 industry partners. We extend sincere gratitude to every customer, expert, and peer who visited our booth. Your keen interest in our portfolio, insightful technical exchanges, and valuable suggestions serve as the driving force for our continuous improvement. While the exhibition has ended, our commitment to collaboration continues!
Moving forward, we remain dedicated to advancing pharmaceutical innovation through higher-quality products and cutting-edge technologies, empowering global health initiatives worldwide.
